Lundbeckfond Ventures et al. invest €11.4m in Nexstim

The round was led by new investor Lundbeckfond Ventures, with new investor Ilmarinen Mutual Pension Insurance Company also joining Nexstim´s existing backers HealthCap and Life Sciences Partners (LSP), as well as Sitra and Finnish Industry Investment.

The fresh funds will notably allow Nexstim to expand its sales and marketing activities in Europe, and take advantage of its recent FDA-clearance for marketing in the USA.

Founded in 2000, Nexstim Oy is a medical device company developing Navigated Brain Stimulation (NBS) solutions for brain diagnostics and therapy.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Nordics
• Healthcare
• Finland
• Life Science Partners